Skip to main content

Endoscopic Transsphenoidal Pituitary Surgery: Results and Complications

  • Chapter
  • First Online:
Transsphenoidal Surgery

Abstract

Endoscopic transsphenoidal pituitary surgery (ETPS) is rapidly replacing both the open transcranial as well as the transsphenoidal microscope-based techniques for resection of pituitary adenomas. This change has resulted from technological advances in lens and camera resolution, minimally invasive surgical instrumentation, and neuronavigation systems, leading to an improved field of view as well as more extensive approaches to skull-base lesions accessed through small portals. Angled endoscopes provide visualization of recesses inside the sella and direct visualization of the medial wall of the cavernous sinus, not accessible by the operating microscope. ETPS is also less invasive, with less postoperative pain, shorter hospitalization, and fewer postoperative complications than microscopic transsphenoidal surgery. The disadvantages include lack of depth perception, the need for an assistant or endoscope holder, and increased incidence of postoperative epistaxis. There is also a steep learning curve, requiring an average of 25–50 operations to learn the techniques necessary to operate using the endoscope. Despite this, experiences with ETPS have largely been positive, with benefits outweighing the costs. In this chapter, we look at the surgical outcomes of functional and nonfunctional pituitary adenomas, and further discuss complications associated with ETPS in general.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Amar AP, et al. Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg. 2002;97(2):307–14.

    CAS  PubMed  Google Scholar 

  2. Anthony JR, et al. Significant elevation of growth hormone level impacts surgical outcomes in acromegaly. Endocr Pract. 2015;21(9):1001–9.

    PubMed  Google Scholar 

  3. Biller BM, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93(7):2454–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Bleier BS, Schlosser RJ. Prevention and management of medial rectus injury. Otolaryngol Clin N Am. 2010;43(4):801–7.

    Google Scholar 

  5. Carija R, Tudor M, Vucina D. Effect of the preoperative use of dopamine agonists in the postoperative course of prolactinomas: a systematic review. Endocr Pract. 2014;20(1):70–4.

    PubMed  Google Scholar 

  6. Ciric I, et al. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery. 1997;40(2):225–36. discussion 236-7.

    CAS  PubMed  Google Scholar 

  7. Colao A, et al. Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study. Clin Endocrinol. 2009;70(5):757–68.

    Google Scholar 

  8. Couldwell WT, Rovit RL, Weiss MH. Role of surgery in the treatment of microprolactinomas. Neurosurg Clin N Am. 2003;14(1):89–92. vii.

    PubMed  Google Scholar 

  9. Creemers SG, et al. Cushing’s syndrome: an update on current pharmacotherapy and future directions. Expert Opin Pharmacother. 2015;16(12):1829–44.

    CAS  PubMed  Google Scholar 

  10. Dallapiazza R, et al. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution. J Neurosurg. 2014;121(3):511–7.

    PubMed  Google Scholar 

  11. Dallapiazza RF, Jane Jr JA. Outcomes of endoscopic transsphenoidal pituitary surgery. Endocrinol Metab Clin N Am. 2015;44(1):105–15.

    Google Scholar 

  12. de Paiva Neto MA, et al. Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol. 2010;72(4):512–9.

    Google Scholar 

  13. Dehdashti AR, et al. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery. 2008;62(5):1006–15. discussion 1015-7.

    PubMed  Google Scholar 

  14. Fatemi N, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008;63(4):709–18. discussion 718-9.

    PubMed  Google Scholar 

  15. Ferreli F, et al. Endoscopic endonasal management of nonfunctioning pituitary adenomas with cavernous sinus invasion: a 10- year experience. Rhinology. 2015;53(4):308–16.

    CAS  PubMed  Google Scholar 

  16. Fougner SL, et al. Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial. Eur J Endocrinol. 2014;171(2):229–35.

    CAS  PubMed  Google Scholar 

  17. Gadhinglajkar SV, Sreedhar R, Bhattacharya RN. Carotid artery injury during transsphenoidal resection of pituitary tumor: anesthesia perspective. J Neurosurg Anesthesiol. 2003;15(4):323–6.

    PubMed  Google Scholar 

  18. Giustina A, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000;85(2):526–9.

    CAS  PubMed  Google Scholar 

  19. Giustina A, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95(7):3141–8.

    CAS  PubMed  Google Scholar 

  20. Gondim JA, et al. Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary. 2010;13(1):68–77.

    PubMed  Google Scholar 

  21. Gupta R, et al. Ischemic complications after pituitary surgery: a report of two cases. J Neurol Surg A Cent Eur Neurosurg. 2013;74(Suppl 1):e119–23.

    PubMed  Google Scholar 

  22. Hadad G, et al. A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope. 2006;116(10):1882–6.

    PubMed  Google Scholar 

  23. Hameed N, et al. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Pituitary. 2013;16(4):452–8.

    CAS  PubMed  Google Scholar 

  24. Hofstetter C, Anand VK, Schwartz TH. Endoscopic transsphenoidal pituitary surgery. Oper Tech Otolaryngol Head Neck Surg. 2011;22(3):206–14.

    Google Scholar 

  25. Hofstetter CP, et al. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus. 2010;29(4):E6.

    PubMed  Google Scholar 

  26. Hofstetter CP, et al. Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary. 2012;15(3):450–63.

    PubMed  Google Scholar 

  27. Hofstetter CP, et al. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus. 2011;30(4):E10.

    PubMed  Google Scholar 

  28. Hu F, et al. Combined use of a gasket seal closure and a vascularized pedicle nasoseptal flap multilayered reconstruction technique for high-flow cerebrospinal fluid leaks after endonasal endoscopic skull base surgery. World Neurosurg. 2015;83(2):181–7.

    PubMed  Google Scholar 

  29. Ivan ME, et al. Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery. J Clin Neurosci. 2015;22(1):48–54.

    PubMed  Google Scholar 

  30. Jalessi M, et al. Impact of nasoseptal flap elevation on sinonasal quality of life in endoscopic endonasal approach to pituitary adenomas. Eur Arch Otorhinolaryngol. 2016;273(5):1199–205.

    PubMed  Google Scholar 

  31. Jane Jr JA, et al. Early outcomes of endoscopic transsphenoidal surgery for adult craniopharyngiomas. Neurosurg Focus. 2010;28(4):E9.

    PubMed  Google Scholar 

  32. Jethwa PR, et al. Cost-effectiveness analysis of microscopic and endoscopic transsphenoidal surgery versus medical therapy in the management of microprolactinoma in the United States. World Neurosurg. 2016;87:65–76.

    PubMed  Google Scholar 

  33. Juraschka K, et al. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. J Neurosurg. 2014;121(1):75–83.

    PubMed  Google Scholar 

  34. Kaltsas GA, et al. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab. 2001;86(4):1645–52.

    CAS  PubMed  Google Scholar 

  35. Karppinen A, et al. Transition from microscopic to endoscopic transsphenoidal surgery for nonfunctional pituitary adenomas. World Neurosurg. 2015;84(1):48–57.

    PubMed  Google Scholar 

  36. Kim EH, et al. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Neurosurgery. 2012;70(5):1106–13. discussion 1113.

    PubMed  Google Scholar 

  37. Kim SH, et al. Emergency endovascular treatment of internal carotid artery injury during a transsphenoidal approach for a pituitary tumor--case report. Yonsei Med J. 2002;43(1):119–22.

    PubMed  Google Scholar 

  38. Komotar RJ, et al. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary. 2012;15(2):150–9.

    PubMed  Google Scholar 

  39. Kreutzer J, et al. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab. 2001;86(9):4072–7.

    CAS  PubMed  Google Scholar 

  40. Laws Jr ER, Barkhoudarian G. The transition from microscopic to endoscopic transsphenoidal surgery: the experience at Brigham and Women’s Hospital. World Neurosurg. 2014;82(6 Suppl):S152–4.

    PubMed  Google Scholar 

  41. Leng LZ, et al. “Gasket-seal” watertight closure in minimal-access endoscopic cranial base surgery. Neurosurgery. 2008;62(5 Suppl 2):ONSE342–3. discussion ONSE343

    PubMed  Google Scholar 

  42. Liebeskind DS. Collateral circulation. Stroke. 2003;34(9):2279–84.

    PubMed  Google Scholar 

  43. Lin BJ, et al. Pituitary abscess following expanding sphenoid sinus pyocele: complication of endoscopic endonasal transsphenoidal surgery. Clin Neurol Neurosurg. 2013;115(8):1502–5.

    PubMed  Google Scholar 

  44. Little AS, et al. Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery. J Neurosurg. 2015;122(6):1458–65.

    PubMed  Google Scholar 

  45. Little AS, et al. Comparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study. J Neurosurg. 2015;123(3):799–807.

    PubMed  Google Scholar 

  46. Lobo B, et al. The expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: a 2014 perspective. Surg Neurol Int. 2015;6:82.

    PubMed  PubMed Central  Google Scholar 

  47. Lonser RR, et al. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. J Neurosurg. 2012;116(2):272–9.

    PubMed  Google Scholar 

  48. Luginbuhl AJ, et al. Endoscopic repair of high-flow cranial base defects using a bilayer button. Laryngoscope. 2010;120(5):876–80.

    PubMed  Google Scholar 

  49. Mao ZG, et al. Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial. Eur J Endocrinol. 2010;162(4):661–6.

    CAS  PubMed  Google Scholar 

  50. Marenco HA, et al. Surgical treatment of non-functioning pituitary macroadenomas by the endoscopic endonasal approach in the elderly. Arq Neuropsiquiatr. 2015;73(9):764–9.

    PubMed  Google Scholar 

  51. Maric A, et al. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience. Croat Med J. 2012;53(3):224–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. McCoul ED, et al. Preservation of multidimensional quality of life after endoscopic pituitary adenoma resection. J Neurosurg. 2015;123(3):813–20.

    PubMed  Google Scholar 

  53. McLaughlin N, et al. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. J Neurosurg. 2013;118(3):613–20.

    PubMed  Google Scholar 

  54. Melmed S, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–88.

    CAS  PubMed  Google Scholar 

  55. Molitch ME. Management of medically refractory prolactinoma. J Neuro-Oncol. 2014;117(3):421–8.

    Google Scholar 

  56. Muhammad A, van der Lely AJ, Neggers SJ. Review of current and emerging treatment options in acromegaly. Neth J Med. 2015;73(8):362–7.

    CAS  PubMed  Google Scholar 

  57. Nakao N, Itakura T. Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma. J Clin Neurosci. 2011;18(1):71–5.

    PubMed  Google Scholar 

  58. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol. 2005;152(3):379–87.

    CAS  PubMed  Google Scholar 

  59. Paluzzi A, et al. Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary. 2014;17(4):307–19.

    PubMed  Google Scholar 

  60. Pant H, et al. Quality of life following endonasal skull base surgery. Skull Base. 2010;20(1):35–40.

    PubMed  PubMed Central  Google Scholar 

  61. Park YS, et al. Emergency endovascular stent graft and coil placement for internal carotid artery injury during transsphenoidal surgery. Surg Neurol. 2009;72(6):741–6.

    PubMed  Google Scholar 

  62. Patel KS, et al. Case-specific protocol to reduce cerebrospinal fluid leakage after endonasal endoscopic surgery. J Neurosurg. 2013;119(3):661–8.

    PubMed  Google Scholar 

  63. Patil CG, et al. Outcomes after repeat transsphenoidal surgery for recurrent Cushing’s disease. Neurosurgery. 2008;63(2):266–70. discussion 270-1.

    PubMed  Google Scholar 

  64. Pereira AM. Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia. Curr Opin Endocrinol Diabetes Obes. 2011;18(4):264–8.

    CAS  PubMed  Google Scholar 

  65. Pereira EA, et al. Transsphenoidal pituitary surgery in the elderly is safe and effective. Br J Neurosurg. 2014;28(5):616–21.

    PubMed  Google Scholar 

  66. Pinar E, et al. Endoscopic endonasal transsphenoidal surgery for pituitary adenomas. J Craniofac Surg. 2015;26(1):201–5.

    PubMed  Google Scholar 

  67. Pita-Gutierrez F, et al. Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis. PLoS One. 2013;8(4):e61523.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Placantonakis DG, et al. Safety of low-dose intrathecal fluorescein in endoscopic cranial base surgery. Neurosurgery. 2007;61(3 Suppl):161–5. discussion 165-6.

    PubMed  Google Scholar 

  69. Pulickal GG, Sitoh YY, Ng WH. Tension pneumocephalus. Singap Med J. 2014;55(3):e46–8.

    Google Scholar 

  70. Raza SM, et al. Sensitivity and specificity of intrathecal fluorescein and white light excitation for detecting intraoperative cerebrospinal fluid leak in endoscopic skull base surgery: a prospective study. J Neurosurg. 2016;124(3):621–6.

    CAS  PubMed  Google Scholar 

  71. Romero ADCB, et al. Managing arterial injury in endoscopic skull base surgery. Operative Neurosurgery. 2015: 1. https://www.youtube.com/watch?v=ZGxexLCNMP0.

  72. Rutkowski MJ, et al. Approach to the postoperative patient with Cushing’s disease. Pituitary. 2015;18(2):232–7.

    CAS  PubMed  Google Scholar 

  73. Salvatori R. Surgical treatment of microprolactinomas: pros. Endocrine. 2014;47(3):725–9.

    CAS  PubMed  Google Scholar 

  74. Sheehan JP, et al. Results of gamma knife surgery for Cushing’s disease. J Neurosurg. 2013;119(6):1486–92.

    PubMed  Google Scholar 

  75. Shen M, et al. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study. Endocr J. 2010;57(12):1035–44.

    PubMed  Google Scholar 

  76. Sowerby LJ, et al. Olfactory and sinonasal outcomes in endoscopic transsphenoidal skull-base surgery. Int Forum Allergy Rhinol. 2013;3(3):217–20.

    PubMed  Google Scholar 

  77. Tabaee A, et al. Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg. 2009;111(3):545–54.

    PubMed  Google Scholar 

  78. Tatemichi TK, et al. Hemodynamic role of ophthalmic artery collateral in internal carotid artery occlusion. Neurology. 1990;40(3 Pt 1):461–4.

    CAS  PubMed  Google Scholar 

  79. Tyrrell JB, et al. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery. 1999;44(2):254–61. discussion 261-3.

    CAS  PubMed  Google Scholar 

  80. Valdemarsson S, et al. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement? Scand J Clin Lab Invest. 2001;61(6):459–70.

    CAS  PubMed  Google Scholar 

  81. Vasilev V, et al. Resistant prolactinomas. J Endocrinol Investig. 2011;34(4):312–6.

    CAS  Google Scholar 

  82. Verhelst J, et al. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab. 1999;84(7):2518–22.

    CAS  PubMed  Google Scholar 

  83. Wang F, et al. Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas. Surg Endosc. 2015;29(6):1270–80.

    PubMed  Google Scholar 

  84. Webster J, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med. 1994;331(14):904–9.

    CAS  PubMed  Google Scholar 

  85. Wong A, et al. Update on prolactinomas. Part 2: treatment and management strategies. J Clin Neurosci. 2015;22(10):1568–74.

    PubMed  Google Scholar 

  86. Woodworth GF, et al. Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus. J Neurosurg. 2014;120(5):1086–94.

    PubMed  PubMed Central  Google Scholar 

  87. Yamada S, et al. Repeat transsphenoidal surgery for the treatment of remaining or recurring pituitary tumors in acromegaly. Neurosurgery. 2010;67(4):949–56.

    PubMed  Google Scholar 

  88. Yildirim AE, et al. Nonfunctioning pituitary adenomas are really clinically nonfunctioning? Clinical and endocrinological symptoms and outcomes with endoscopic endonasal treatment. World Neurosurg. 2016;85:185–92.

    PubMed  Google Scholar 

  89. Yorgason JG, et al. Endoscopic decompression of tension pneumosella following transsphenoidal pituitary tumor resection. Pituitary. 2004;7(3):171–7.

    PubMed  Google Scholar 

  90. Zhan R, et al. Pure endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary adenomas in the elderly: surgical outcomes and complications in 158 patients. World Neurosurg. 2015;84(6):1572–8.

    PubMed  Google Scholar 

  91. Zhang X, et al. Hemorrhagic pituitary macroadenoma: characteristics, endoscopic endonasal transsphenoidal surgery, and outcomes. Ann Surg Oncol. 2011;18(1):246–52.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Theodore H. Schwartz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Singh, H., Essayed, W.I., Hussain, I., Yang, K., Anand, V.K., Schwartz, T.H. (2017). Endoscopic Transsphenoidal Pituitary Surgery: Results and Complications. In: Laws, Jr, E.R., Cohen-Gadol, A.A., Schwartz, T.H., Sheehan, J.P. (eds) Transsphenoidal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-56691-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56691-7_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56689-4

  • Online ISBN: 978-3-319-56691-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics